City National Bank of Florida’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Buy
1,932
+445
+30% +$455K 0.97% 22
2026
Q1
$1.37M Sell
1,487
-368
-20% -$373K 0.82% 21
2025
Q4
$1.99M Buy
1,855
+283
+18% +$271K 1.3% 14
2025
Q3
$1.2M Buy
1,572
+67
+4% +$49.9K 0.79% 18
2025
Q2
$1.17M Buy
1,505
+591
+65% +$459K 0.85% 23
2025
Q1
$755K Buy
914
+103
+13% +$85.7K 0.68% 25
2024
Q4
$626K Buy
+811
New +$672K 0.57% 31

Other funds holding LLY

City National Bank of Florida's LLY Position: Q2 2026 in Review

City National Bank of Florida increased its Eli Lilly (LLY) stake by 30% in Q2 2026, buying an estimated $455K and bringing the position to 1,932 shares worth $2.32M. The position accounts for 0.97% of the portfolio, ranked #22.

City National Bank of Florida first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 3,650 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • City National Bank of Florida held 1,932 shares of Eli Lilly worth $2.32M as of Q2 2026.
  • City National Bank of Florida bought 445 Eli Lilly shares in Q2 2026, an estimated $455K.
  • Eli Lilly made up 0.97% of City National Bank of Florida's portfolio in Q2 2026, its #22 holding.
  • City National Bank of Florida first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 3,650 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on City National Bank of Florida's 13F filing for Q2 2026, filed 15 Jul 2026.